Ciclesonide and FP were recovered in almost all samples. In case of normal distribution we would use parametric t-test to compare the mean values between two groups. I have read and accept the Wiley Online Library Terms and Conditions of UseComparison of adverse events associated with different spacers used with non-extrafine beclometasone dipropionate for asthma, Inhalational Ciclesonide found beneficial in prevention of fat embolism syndrome and improvement of hypoxia in isolated skeletal trauma victims, Erratum to: Safety Considerations of Inhaled Corticosteroids in the Elderly, Safety Considerations of Inhaled Corticosteroids in the Elderly, Efficacy and safety of high-dose ciclesonide for the treatment of severe asthma, Pharmacokinetic and Pharmacodynamic Properties of Inhaled Ciclesonide, Equivalence Considerations for Orally Inhaled Products for Local Action—ISAM/IPAC-RS European Workshop Report, Journal of Aerosol Medicine and Pulmonary Drug Delivery, The Efficacy of Immediate Diet for Reducing Local Adverse Events of Inhaled Corticosteroid: A Pilot Study, Repeated-Dose Pharmacokinetics of Inhaled Ciclesonide (CIC-HFA) in Japanese Children with Bronchial Asthma: A Phase I Study, Successful treatment of eosinophilic esophagitis with ciclesonide, Adrenal suppression: A practical guide to the screening and management of this under-recognized complication of inhaled corticosteroid therapy, Pulmonary Drug Metabolism, Clearance, and Absorption, Efficacy and safety of ciclesonide in patients with severe asthma: a 12-week, double-blind, randomized, parallel-group study with long-term (1-year) follow-up, Similar Results in Children with Asthma for Steady State Pharmacokinetic Parameters of Ciclesonide Inhaled with or without Spacer, Cortisol suppression as a surrogate marker for inhaled corticosteroid-induced growth retardation in children, Clinical Pharmacokinetic and Pharmacodynamic Profile of Inhaled Ciclesonide, Similar Efficacy of Ciclesonide Once Daily Versus Fluticasone Propionate Twice Daily in Patients with Persistent Asthma, Evidence-Based Selection of Inhaled Corticosteroid for Treatment of Chronic Asthma, A worldwide yearly survey of new data and trends in adverse drug reactions and interactions, Comparison of twice-daily inhaled ciclesonide and fluticasone propionate in patients with moderate-to-severe persistent asthma, Pharmacological properties and clinical effects of the inhaled corticosteroid ciclesonide (Alvesco® inhaler) for treatment of asthma, In vitro metabolism of beclomethasone dipropionate, budesonide, ciclesonide, and fluticasone propionate in human lung precision-cut tissue slices, Pharmacokinetic and pharmacodynamic properties important for inhaled corticosteroids, Corticosteroids (inhaled and/or intranasal) in the treatment of respiratory allergy in children: safety vs. efficacy, Randomized comparison of the efficacy and safety of ciclesonide and budesonide in adolescents with severe asthma, Ciclesonide: a new inhaled corticosteroid with improved pharmacologic characteristics, Impact of inhaled corticosteroid-induced oropharyngeal adverse events: results from a meta-analysis, Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review, High lung deposition of 99mTc-labeled ciclesonide administered via HFA-MDI to patients with asthma, Innovations thérapeutiques dans le traitement de l'asthme et de la BPCO : inhibiteurs des PDE4, atropiniques et corticostéroïdes, Revue Française d'Allergologie et d'Immunologie Clinique, Comparative efficacy of once-daily ciclesonide and budesonide in the treatment of persistent asthma, Ciclesonide Reduces the Need for Oral Steroid Use in Adult Patients With Severe, Persistent Asthma, The newly developed inhaled corticosteroid ciclesonide for the treatment of asthma, Comparable efficacy of ciclesonide once daily versus fluticasone propionate twice daily in asthma, The systemic safety of inhaled corticosteroid therapy: a focus on ciclesonide, Once-daily ciclesonide in children: Efficacy and safety in asthma, Ciclesonide: a novel inhaled corticosteroid for the treatment of persistent asthma – a pharmacologic and clinical profile, Comparative Pharmacology, Bioavailability, Pharmacokinetics, and Pharmacodynamics of Inhaled Glucocorticosteroids, Effect of ciclesonide and fluticasone on hypothalamicpituitary-adrenal axis function in adults with mild-to-moderate persistent asthma, Ciclesonide, a Novel Inhaled Steroid, Does Not Affect Hypothalamic-Pituitary-Adrenal Axis Function in Patients With Moderate-to-Severe Persistent Asthma, Once-daily ciclesonide 80 or 320μg for 12 weeks is safe and effective in patients with persistent asthma, Ciclesonide: a novel inhaled corticosteroid for the treatment of persistent asthma - a pharmacologic and clinical profile, Model-Based Covariate Pharmacokinetic Analysis and Lack of Cortisol Suppression by the New Inhaled Corticosteroid Ciclesonide Using a Novel Cortisol Release Model, Preclinical Profile of Ciclesonide, a Novel Corticosteroid for the Treatment of Asthma, Journal of Pharmacology and Experimental Therapeutics,